Arrowhead is up 444% since the beginning of their PI HBV trial. This has now ended, but was just a safety trial so no efficacy has been shown to date.
This despite massive dilution six months ago when they raised $60m. They also raised $104m yesterday.
Something to keep in mind if you are considering selling.
- Forums
- ASX - By Stock
- BLT
- we'll soon be talking dollars not cents
we'll soon be talking dollars not cents, page-30
-
-
- There are more pages in this discussion • 37 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)